Bramstedt Discusses GLP-1 Litigation at American Bar Association Program

Article Details

Published:

Read Time:

1 min read

Follow Us:

Associated Attorney(s)

Emilee M. Bramstedt
Colleagues, clients, and judges in both state and federal courts comment on Emilee M. Bramstedt’s dedication, commitment, work ethic, and zealous advocacy, appreciating the attention to detail she puts into each case. She’s successfully represented a wide range of clients – from Fortune 500 companies to small businesses to individuals – and handled a wide range of legal issues, including complex, multi-party civil cases and class actions (such as consumer fraud class actions and mass actions involving pharmaceuticals, medical devices, and other products liability) as well as personal injury/wrongful death, premises liability, and property damage matters. She’s litigated cases throughout central and southern Illinois (including St. Clair, Madison, and Sangamon Counties and various counties in between), while also handling matters in St. Louis City, Missouri.

Share this Article

GLP-1 receptor agonists have transformed the treatment of diabetes and obesity and generated one of the fastest-growing litigation dockets in the country. At an upcoming American Bar Association (ABA) program, a panel that includes HeplerBroom attorney Emilee Bramstedt will provide a comprehensive update on GLP-1 litigation, including the status of multi-district litigation, key rulings on causation and warning claims, and the science behind alleged injuries. The session is part of ABA’s 2026 Products Liability & Life Sciences Regional CLE Program, which will be held in Philadelphia October 21-22. More information about the program is available on ABA’s website.

Bramstedt, an associate in the firm’s Edwardsville office, has defended clients ranging from Fortune 500 companies to small businesses and individuals in matters involving pharmaceuticals, medical devices, and other product liability matters. She has experience handling a variety of legal issues, including complex multiparty class actions.

Recent Articles